SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / ORD SHS
Total 13F shares
26,936,375
Share change
+202,011
Total reported value
$269,906,603
Price per share
$10.02
Number of holders
63
Value change
+$1,995,605
Number of buys
24
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q3 2014

As of 30 Sep 2014, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,936,375 shares. The largest 10 holders included RIMA SENVEST MANAGEMENT, L.L.C., Visium Asset Management, LP, NORTH TIDE CAPITAL, LLC, BAUPOST GROUP LLC/MA, BRANDES INVESTMENT PARTNERS, LP, JPMORGAN CHASE & CO, Broadfin Capital, LLC, ROYCE & ASSOCIATES LLC, HOURGLASS CAPITAL, LLC, and GRANAHAN INVESTMENT MANAGEMENT INC/MA. This page lists 63 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.